Real-time enrollment status for this metastatic microsatellite stable colorectal carcinoma clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 11:50 AM UTC
| NCT Number | NCT06654037 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Microsatellite Stable Colorectal Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 39 participants |
| Active Locations | 8 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | July 31, 2026 (4 weeks ago) |
As of August 29, 2026: Clinical trial NCT06654037 is currently recruiting participants. This phase1 study for metastatic microsatellite stable colorectal carcinoma is actively seeking new participants at 8 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06654037 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06654037 was last updated 4 weeks ago (July 31, 2026). HelloStudys verifies this status automatically.